Posts Tagged Ann Falsey

An interim analysis of study data from a coronavirus vaccine being developed by Pfizer and BioNTech indicates that the vaccine is highly effective in preventing COVID-19. Researchers and volunteers in Rochester have been involved in the testing of the vaccine since May, when the first human studies were launched, and technologies used in the development of the vaccine can trace their origins to decades of infectious disease research conducted at the University of Rochester Medical Center.

The Medical Center’s Ann Falsey and Angela Branche, both with the Vaccine and Treatment and Evaluation Unit, are leading an NIH-sponsored clinical trial of remdesivir in the treatment of COVID-19.